FDA Pushes Back Orforglipron Decision to April as National Priority Voucher Program Hits Early Turbulence
The FDA has delayed its decision on Eli Lilly's oral obesity pill orforglipron from March 28 to April 10, alongside delays for three other drugs in the new expedited review program.
4 min read5 sources